Clinical factors associated with increase in serum transthyretin levels at 1-year with tafamidis in wild-type transthyretin amyloid cardiomyopathy.
- DOI
- 10.1016/j.jjcc.2026.07.022
- Published
- 2026 Aug 31
- Container
- Journal of cardiology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jjcc.2026.07.022,
title = {Clinical factors associated with increase in serum transthyretin levels at 1-year with tafamidis in wild-type transthyretin amyloid cardiomyopathy.},
author = {Yoshie K and Yoshinaga T and Minamisawa M and Motoki H and Aoki T and Nishikawa K and Suzuki S and Okuma Y and Kimura K and Sekijima Y and Kuwahara K},
year = {2026},
journal = {Journal of cardiology},
doi = {10.1016/j.jjcc.2026.07.022},
url = {https://doi.org/10.1016/j.jjcc.2026.07.022}
}RIS
TY - JOUR TI - Clinical factors associated with increase in serum transthyretin levels at 1-year with tafamidis in wild-type transthyretin amyloid cardiomyopathy. AU - Yoshie K AU - Yoshinaga T AU - Minamisawa M AU - Motoki H AU - Aoki T AU - Nishikawa K AU - Suzuki S AU - Okuma Y AU - Kimura K AU - Sekijima Y AU - Kuwahara K PY - 2026 JO - Journal of cardiology DO - 10.1016/j.jjcc.2026.07.022 UR - https://doi.org/10.1016/j.jjcc.2026.07.022 ER -
APA
K, Y., T, Y., M, M., H, M., T, A., K, N., S, S., Y, O., K, K., Y, S., & K, K. (2026). Clinical factors associated with increase in serum transthyretin levels at 1-year with tafamidis in wild-type transthyretin amyloid cardiomyopathy.. Journal of cardiology. https://doi.org/10.1016/j.jjcc.2026.07.022
Source records
- pubmed · retrieved 2026-09-26T23:36:16.703Z